DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy (Q73645101)
Jump to navigation
Jump to search
scientific article published on 01 March 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy |
scientific article published on 01 March 2000 |
Statements
DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy (English)
P J van de Vaart
J Belderbos
D de Jong
K C Sneeuw
D Majoor
H Bartelink